Impact of the implementation of an evidence-based guideline on diagnostic testing, management, and clinical outcomes for infants with bronchiolitis
Open Access
- 19 August 2016
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 10 (5) , 425-434
Abstract
Although bronchiolitis poses a significant health problem in low- and middle-income countries (LMICs), to the best of our knowledge, to date it has not been determined whether evidence-based bronchiolitis clinical practice guidelines (CPGs) complemented by standardized educational strategies reduce the use of unnecessary diagnostic tests and medications and improve clinically important outcomes in LMICs. In an uncontrolled before and after study, we assessed the impact of the implementation of an evidence-based bronchiolitis CPG on physician behavior and the care of infants with bronchiolitis by comparing pre-guideline (March to August 2014) and post-guideline (March to August 2015) use of diagnostic tests and medications through an electronic medical record review in a children’s hospital in Bogota, Colombia. We also sought to assess the impact of the implementation of the CPG on clinically important outcomes such as lengths of stay, hospital admissions, intensive care admissions, and hospital readmissions. Data from 662 cases of bronchiolitis (pre-guideline period) were compared with the data from 703 cases (post-guideline period). On comparing the pre- and post-guideline periods, it was seen that there was a significant increase in the proportion of patients with an appropriate diagnosis and treatment of bronchiolitis (36.4% versus 44.5%, p = 0.003), and there were statistically significant decreases in the use of a hemogram (33.2% versus 26.6%, p=0.010), procalcitonin (3.9% versus 1.6%, p=0.018), nebulized beta-2 agonists (45.6% versus 3.4%, p < 0.001), nebulized anticholinergics (3.3% versus 1.4%, p= 0.029), and nebulized epinephrine (16.2% versus 7.8%, p < 0.001). Likewise, a significant increase in the use of nebulized hypertonic saline was seen (79.6% versus 91.7%, p < 0.001). However, implementation of the CPG for bronchiolitis was not associated with significant changes in clinically important outcomes. The development and implementation of a good quality bronchiolitis CPG is associated with a significant increase in the proportion of cases with an appropriate diagnosis and treatment of the disease in the context of a university-based hospital located in the capital of an LMIC. However, we could not demonstrate an improvement in clinically important outcomes such as any of the bronchiolitis severity parameters.Keywords
This publication has 18 references indexed in Scilit:
- Quality assessment of acute viral bronchiolitis clinical practice guidelinesJournal of Evaluation in Clinical Practice, 2015
- Overuse of bronchodilators and steroids in bronchiolitis of different severityAllergologia et Immunopathologia, 2014
- Manejo de la bronquiolitis aguda en atención primaria: análisis de variabilidad e idoneidad (proyecto aBREVIADo)Anales de Pediatría, 2013
- [Cost-effectiveness of chest x-rays in infants with clinically suspected viral bronchiolitis in Colombia].2011
- AGREE II: advancing guideline development, reporting and evaluation in health careCanadian Medical Association Journal, 2010
- Management of acute bronchiolitis: can evidence based guidelines alter clinical practice?Thorax, 2008
- Economic Impact of Respiratory Syncytial Virus-Related Illness in the USPharmacoEconomics, 2004
- Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000The Journal of Pediatrics, 2003
- An Evidence-Based Clinical Pathway for Bronchiolitis Safely Reduces Antibiotic OveruseAmerican Journal of Medical Quality, 2002
- Sustaining the Implementation of an Evidence-Based Guideline for BronchiolitisArchives of Pediatrics & Adolescent Medicine, 2000